Cascade genetic testing (CGT) female first-degree relatives (FDR) of men with germline BRCA2 mutations (g BRCA2 mut) and prostate cancer (PCa): A cost-effectiveness analysis.
In: Journal of Clinical Oncology, Jg. 41 (2023-06-02), S. e17099
Online
academicJournal
Zugriff:
Titel: |
Cascade genetic testing (CGT) female first-degree relatives (FDR) of men with germline BRCA2 mutations (g BRCA2 mut) and prostate cancer (PCa): A cost-effectiveness analysis.
|
---|---|
Autor/in / Beteiligte Person: | Carletti, Alexie A ; Caughey, Aaron B ; Sokolova, Alexandra |
Link: | |
Zeitschrift: | Journal of Clinical Oncology, Jg. 41 (2023-06-02), S. e17099 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 0732-183X (print) |
DOI: | 10.1200/JCO.2023.41.16_suppl.e17099 |
Sonstiges: |
|